Full Coverage

NicOx announces initiation of first phase 1 study of investigational nitric oxide-donating agent...

tmcnet.com
May 13, 2008
        
Story Timeline:  193 days

NicOx announces initiation of first phase 1 study of investigational nitric oxide-donating agent in hypertensive patients by Merck & Co., Inc. ... Via Acquire Media NewsEdge) May 13, 2008. Sophia Antipolis, France. www.nicox.com NicOx S.A. (Eurolist: COX) today announced... [read full story]                    

Add Comment
Latest article on this story:

NicOx Announces Initiation Of First Phase 1 Study Of Investigational Nitric Oxide-Donating Agent...

 medicalnewstoday.com May 14, 2008
First article on this story:

NicOx announces initiation of first phase 1 study of investigational nitric oxide-donating agent...

 newsblaze.com May 13, 2008
Selected publications with coverage of this story:
redorbit.com prnewswire.com medicalnewstoday.com bionity.com newsblaze.com tmcnet.com finanznachrichten.de
RELATED
Found 8 documents:

NicOx Announces Initiation Of First Phase 1 Study Of Investigational Nitric Oxide-Donating Agent...

medicalnewstoday.com
May 14, 2008
        

NicOx S.A. (Eurolist: COX) announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies' collaborative agreement to develop new nitric oxide-donating antihypertensive agents using NicOx'...

                   

NicOx Reports First Quarter 2008 Financial Results

finanznachrichten.de
May 14, 2008
        

SOPHIA ANTIPOLIS, France, May 14 /PRNewswire-FirstCall/ -- On March 31, 2008, the Company had cash, cash equivalents and financial instruments of euro 153.7 million, compared to euro 201.2 million on March 31, 2007. Review of the consolidated financial results for the three months ended March 31,...

                   

NicOx reports first quarter 2008 financial results

newsblaze.com
May 14, 2008
        

Sophia Antipolis, France. www.nicox.com NicOx S.A. (Eurolist: COX) today reported financial results for the first three months of 2008. On March 31, 2008, the Company had cash, cash equivalents and financial instruments of EUR 153.7 million, compared to EUR 201.2 million on March 31, 2007. Review...

                   

NicOx reports first quarter 2008 financial results

tmcnet.com
May 14, 2008
        

SOPHIA ANTIPOLIS, FRANCE, May 14 / MARKET WIRE/ -- Sophia Antipolis, France. www.nicox.com NicOx S.A. (Eurolist: COX) today reported financial results for the first three months of 2008. On March 31, 2008, the Company had cash, cash equivalents and financial instruments of EUR 153.7 million,...

NicOx announces initiation of first phase 1 study of investigational nitric oxide-donating agent...

bionity.com
May 13, 2008
        

14 May 2008 - NicOx S.A. announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies' collaborative agreement to develop new nitric oxide-donating antihypertensive agents using NicOx' proprietary...

NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent...

redorbit.com
May 13, 2008
        

Posted on: Tuesday, 13 May 2008, 03:00 CDT May 13, 2008. Sophia Antipolis, France. www.nicox.com NicOx S.A. (Eurolist: COX) today announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies' collaborative...

Nicox says Merck starts phase 1 study for treatment of hypertensive patients

finanznachrichten.de
May 13, 2008
        

PARIS (Thomson Financial) - NicOx SA said Merck & Co Inc has initiated the first in a series of planned clinical studies in mild to moderate hypertensive ... ... PARIS (Thomson Financial) - NicOx SA has initiated the first in a series of planned clinical studies in mild...

NicOx announces initiation of first phase 1 study of investigational nitric oxide-donating agent...

newsblaze.com
May 13, 2008
        

May 13, 2008. Sophia Antipolis, France. www.nicox.com ... Sophia Antipolis, France. www.nicox.com NicOx S.A. (Eurolist: COX) today announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients,...